Per-cycle dose decisions belong with a licensed physician
Once-weekly formulations like semaglutide reach steady-state concentrations after approximately 45 weeks, while dulaglutide reaches steady state within 2-4 weeks
During the item generation and discussion and clarification phases, the experts identified 14 distinct challenges: costs, supply challenges, lack of evidence, polypharmacy, barriers to prescription, lack of knowledge, adherence concerns, aversion to injection therapy, clinical inertia, titration needs, perceived health state, fear of adverse effects, lack of clinical guideline recommendations, and lack of measurable outcomes to guide therapy
The Lean Mass Question The more pressing clinical concern is whats happening to body composition
If theres any silver lining in this cancer journey, its the fact that we caught it early